Q3 2025 Earnings Call Transcript November 7, 2025 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is ...
New trial results reveal ITM-11 significantly improves survival rates in GEP-NET patients, outperforming everolimus with ...
Daraxonrasib received FDA orphan drug designation for pancreatic cancer, targeting RAS mutations in pancreatic ductal ...
Impaired lung function is associated with both the prevalence and incidence of SpA, with the strongest effects observed in axSpA and AS.
Scientists filmed 36 snake species to study their strike speed. They found vipers, elapids, and colubrids each use unique ...
The MarketWatch News Department was not involved in the creation of this content.-- Lenire is now Tinnitus UK's safest and most effective available tinnitus treatment option follo ...
MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...
LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...
Learn more about whether Post Holdings, Inc. or Pilgrim's Pride Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Barchart on MSN
Coffee Prices Sharply Higher as ICE Inventories Shrink
December arabica coffee (KCZ25) on Friday closed up +11.05 (+2.79%), and January ICE robusta coffee (RMF26) closed up +118 ...
Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback